Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Cancer statistics for the year 2020: An overview
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
C118P, a novel microtubule inhibitor with anti-angiogenic and vascular disrupting activities, exerts anti-tumor effects against hepatocellular carcinoma
Mei Yang et al.
BIOCHEMICAL PHARMACOLOGY (2021)
The role of immunotherapy and molecular-targeted therapy in the treatment of melanoma
Paulina Stachyra-Strawa et al.
ONCOLOGY REPORTS (2021)
Targeting Mps1 in combination with paclitaxel inhibits osteosarcoma progression by modulating spindle assembly checkpoint and Akt/mTOR signaling
Lu Lu et al.
ONCOLOGY LETTERS (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway
Jiannan Qiu et al.
CANCER MEDICINE (2020)
Immunotherapy of Melanoma: Facts and Hopes
Sarah A. Weiss et al.
CLINICAL CANCER RESEARCH (2019)
Adapalene suppressed the proliferation of melanoma cells by S-phase arrest and subsequent apoptosis via induction of DNA damage
Hongyang Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
The Emerging Role of Surgery for Patients With Advanced Melanoma Treated With Immunotherapy
Charles J. Puza et al.
JOURNAL OF SURGICAL RESEARCH (2019)
Incidence, Outcomes and Predictors of Primary Central Nervous System Melanoma: A SEER-Based Study
Weitao Man et al.
WORLD NEUROSURGERY (2019)
Melanoma in children, adolescents and young adults: anatomo-clinical features and prognostic study on 426 cases
Giovanni Bagnoni et al.
PEDIATRIC SURGERY INTERNATIONAL (2019)
Total saponins of Albiziae Cortex show anti-hepatoma carcinoma effects by inducing S phase arrest and mitochondrial apoptosis pathway activation
Yi Qian et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Melanoma diagnosis: predictive value of macroscopic changes observed by the patient
Isabelle Tromme et al.
MELANOMA RESEARCH (2018)
Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients
Liping Zhuang et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Preclinical Pharmacokinetics of C118P, a Novel Prodrug of Microtubules Inhibitor and Its Metabolite C118 in Mice, Rats, and Dogs
Cang Zhang et al.
MOLECULES (2018)
The rapidly evolving therapies for advanced melanoma-Towards immunotherapy, molecular targeted therapy, and beyond
Ziqiang Zhu et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Targeted Therapies in Melanoma: Translational Research at Its Finest
Allen W. Ho et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Optimal Management of Metastatic Melanoma: Current Strategies and Future Directions
Marta Batus et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2013)
The Spindle Assembly Checkpoint
Pablo Lara-Gonzalez et al.
CURRENT BIOLOGY (2012)
Mitosis-targeted anti-cancer therapies: where they stand
K-S Chan et al.
CELL DEATH & DISEASE (2012)
Bub1 and BubR1: at the Interface between Chromosome Attachment and the Spindle Checkpoint
Sabine Elowe
MOLECULAR AND CELLULAR BIOLOGY (2011)
Microtubule-associated proteins as targets in cancer chemotherapy
Kumar M. R. Bhat et al.
CLINICAL CANCER RESEARCH (2007)
Differential promoter methylation may be a key molecular mechanism in regulating BubR1 expression in cancer cells
Hye-Young Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2007)
c-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression
Yuji Nakata et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
MAD2-induced sensitization to vincristine is associated with mitotic arrest and Raf/Bcl-2 phosphorylation in nasopharyngeal carcinoma cells
XH Wang et al.
ONCOGENE (2003)
Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability
HJ Shin et al.
CANCER CELL (2003)
Share Paper
